A presentation of Taugagreining hf from 2003.

1. Taugagreining (e. “Neural analysis”) Egill Másson

2. Taugagreining’s Mission To advance and promote the use of EEG technology as an aid in the diagnosis and therapy of neurological disorders.

3. Why EEG? Increasing emphasis on brain disoprder prevention and treatment . EEG is only real time functional brain measurement on millisecond basis. Necessary for determining epileptic activity. Substitute methods not yet in sight.

5. Organization

6. Operations

7. Products Clinical EEG Routine Diagnostic EEG Core product Epilepsy Monitoring Released april 2002 EEG Monitor Released october 2001

8. Routine EEG Core product Incredible ease of use Intuitive Quick Robust Protocols Major Accounts King’s, Lund, Zurich, Kaiser

9. Epilepsy Monitoring Compact high quality 32/64/128 channels Detections Alarms Trends Continuous Impedance Estimation

10. Monitor – EEG for the ICU Unlimited Recording Clear Presentation Online analysis Easy to Use Compact Instant access to raw data Touch-screen Alarms Neonatal emphasis

11. Oxford Performance

12. Oxford Relationship 1996-2003 Oxford manufacture Oxford stock Oxford market outside Scand TG sell in Scandinavia Oxford sell ROW 2003 - TG Manufacture TG stock (3PL) TG market worldwide Oxford sell in USA, UK, Benelux, Spain TG sell ROW

13. Effects of change on operations Revenues from EEG outside Scandinavia change from license fees to product sales Those revenues increase fourfold (other things being equal) Margin from those revenues doubles Increase of capital bound in stock, and receivables

14. New supply chain

15. Operational changes 3 new staff added to Sales and Marketing in 2002 1 new staff added to Technical Support in 2002 1 new staff added to Sales and Marketing in 2002 All infrastructure in place.

16. EEG distribution Oxford Instruments subsidiaries in USA, UK, Benelux, Spain, Italy, France 31 ind. distributors in Far East 20 ind. distributors in Middle East and Africa 11 ind. distributors in Europe (rest of) Spooner Medical with >20 subagents in former Soviet Union

17. EEG in New Places Anesthesia monitoring in the OR Ischemic stroke detection Sedation monitoring in the ICU and OR Advanced seizure detection Alzheimer screening Attention deficit disorder screenin